One of the major events for virtual business development and licensing is back, from November 27th to December 1st, 2023. As a partner of the event, BioArk is pleased to offer Valais life science actors a promo code to participate and enhance their business opportunities! The Biotechgate Digital Partnering virtual event is designed to support …
Biotechgate Digital Partnering is back in November Read More »
Debiopharm is to build a new Innovation building dedicated to research and development at its Valais site in Martigny. The Lausanne-based biopharmaceutical group will invest CHF 30 million in the project…
From dynamite to pharmaceuticals, Valsynthèse, the ‘fine chemistry’ business unit of the Société Suisse des Explosifs, celebrates four decades of steering innovative chemical solutions in Valais.
BioArk is on a roll! The Monthey-based technology site, which celebrates its 20th anniversary this year, inaugurated its third building on Friday.
The pharmaceutical and biotechnology group Lonza has confirmed the extension of a long-term collaboration with a major global biopharmaceutical partner. The agreement will quadruple current bioconjugation capacity at the Ibex facilities in Visp. The new suites are expected to be operational in 2026 and will generate approximately 180 jobs, according to Lonza.
The Institute of Life Technologies of the School of Engineering of the HES-SO Valais-Wallis has sealed…
The Institute of Life Technologies of the School of Engineering of the HES-SO Valais-Wallis has sealed…
Two Swiss jewels in the crown of pharmaceutical subcontracting rank 1st and 6th in the world ranking published by Genetic Engineering & Biotechnology News. Proof of a booming sector in our canton.
GaDia SA, a Valais-based start-up specializing in the development of diagnostic tests, and HES-SO Valais-Wallis are to collaborate on the development of a new-generation rapid test for the detection of fungal infections such as Invasive Pulmonary Aspergillosis (IPA). This research project is supported by Innosuisse, the Swiss innovation promotion agency, to the tune of CHF 350,000.
Swiss company ten23 health has just announced an increase in capacity for the manufacture of sterile…
Sion Site
Rue de l’Industrie 23
CH-1950 Sion
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Monthey Site
Rte de l’Ile-au-bois 1A
CH-1870 Monthey
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Massimo Nobile
| BioArk | Book a meeting room
